Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Nicotinamide Riboside

    Client Email Product

    Nicotinamide Riboside

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    1
    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    1
    API REF. PRICE (USD / KG)
    914

    API Market Place

    2
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    11
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients
    A Milestone Clinical Study Reveals that Elevating Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Supplementation Effectively Reduces Inflammation in Both Healthy Subjects and Immune Cells Derived from Psoriasis Patients

    https://www.businesswire.com/news/home/20231002427548/en

    BUSINESSWIRE
    02 Oct 2023
    Share Share
    Thorne Research, Inc. Loses Patent Challenge Decision
    Thorne Research, Inc. Loses Patent Challenge Decision

    https://www.businesswire.com/news/home/20220815005235/en

    BUSINESSWIRE
    15 Aug 2022
    Share Share
    ChromaDex Shares Findings from First-Ever Peer-Reviewed Published Clinical Study
    ChromaDex Shares Findings from First-Ever Peer-Reviewed Published Clinical Study

    https://www.businesswire.com/news/home/20220302005311/en

    BUSINESSWIRE
    02 Mar 2022
    Share Share
    ChromaDex Announces Results of New Pilot Clinical Trial of NR Supplementation
    ChromaDex Announces Results of New Pilot Clinical Trial of NR Supplementation

    https://www.businesswire.com/news/home/20220125005438/en

    BUSINESSWIRE
    25 Jan 2022
    Share Share
    ChromaDex and Designs for Health Partner for New Product Development on Niagen
    ChromaDex and Designs for Health Partner for New Product Development on Niagen

    https://www.businesswire.com/news/home/20220120005167/en

    BUSINESSWIRE
    20 Jan 2022
    Share Share
    ChromaDex Shares PC Research Findings and Scientific Initiations from CERP
    ChromaDex Shares PC Research Findings and Scientific Initiations from CERP

    https://www.businesswire.com/news/home/20210920005122/en

    BUSINESSWIRE
    20 Sep 2021
    Share Share
    New Preclinical Study Finds Nicotinamide Riboside May Improve Immune Cell
    New Preclinical Study Finds Nicotinamide Riboside May Improve Immune Cell

    https://investors.chromadex.com/news/news-details/2020/New-Preclinical-Study-Finds-Nicotinamide-Riboside-May-Improve-Immune-Cell-Function/default.aspx

    PRESSRELEASE
    08 Oct 2020
    Share Share
    Taysha Partners with Invitae to Enable Rapid Access to Genetic Testing
    Taysha Partners with Invitae to Enable Rapid Access to Genetic Testing

    https://www.businesswire.com/news/home/20201006005450/en

    BUSINESSWIRE
    06 Oct 2020
    Share Share
    ChromaDex Launches Tru Niagen® Pro 500,Patented Nicotinamide Riboside
    ChromaDex Launches Tru Niagen® Pro 500,Patented Nicotinamide Riboside

    https://www.globenewswire.com/news-release/2019/12/11/1959101/0/en/ChromaDex-Launches-Tru-Niagen-Pro-500-the-Largest-Serving-of-Patented-Nicotinamide-Riboside-Available-Worldwide.html

    GLOBENEWSWIRE
    11 Dec 2019
    Share Share
    New Study Demonstrates a Unique Role of Nicotinamide Riboside
    New Study Demonstrates a Unique Role of Nicotinamide Riboside

    https://www.biospace.com/article/releases/new-study-demonstrates-a-unique-role-of-nicotinamide-riboside-over-other-nad-precursors/?s=95

    BIOSPACE
    18 Oct 2019
    Share Share
    Tru Niagen (Nicotinamide riboside) : ChromaDex vs. Elysium Health
    Tru Niagen (Nicotinamide riboside) : ChromaDex vs. Elysium Health

    https://insight.rpxcorp.com/litigation_documents/13072324

    PATENT LITIGATION
    22 Sep 2018
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search